(Q37867100)

24 August 2017

1 reference

title

Influenza virosomes as a vaccine adjuvant and carrier system (English)

1 reference

24 August 2017

1 reference

1 reference

Christian Moser

1

1 reference

24 August 2017

Mario Amacker

series ordinal

2

1 reference

24 August 2017

Rinaldo Zurbriggen

series ordinal

3

1 reference

24 August 2017

publication date

1 April 2011

1 reference

Expert Review of Vaccines

24 August 2017

published in

1 reference

24 August 2017

volume

10

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

437-446

1 reference

Immunology of vaccine adjuvants

24 August 2017

cites work

1 reference

Vaccine adjuvants: current challenges and future approaches.

21 January 2018

1 reference

Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns

21 January 2018

1 reference

Toll or toll-free adjuvant path toward the optimal vaccine development

21 January 2018

1 reference

Targeting the innate immune response with improved vaccine adjuvants

21 January 2018

1 reference

Immunology of TLR-independent vaccine adjuvants

21 January 2018

1 reference

Mechanism of action of licensed vaccine adjuvants

21 January 2018

1 reference

Vaccine Adjuvants: Putting Innate Immunity to Work

21 January 2018

1 reference

Duration, combination and timing: the signal integration model of dendritic cell activation

21 January 2018

1 reference

Vaccine adjuvants: scientific challenges and strategic initiatives

21 January 2018

1 reference

Regulatory considerations on new adjuvants and delivery systems

21 January 2018

1 reference

Mode of action of adjuvants: implications for vaccine safety and design

21 January 2018

1 reference

Virus-like particles: passport to immune recognition

21 January 2018

1 reference

The coming of age of virus-like particle vaccines

21 January 2018

1 reference

Influenza virus-like particle vaccines

21 January 2018

1 reference

Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A

21 January 2018

1 reference

Virus-like particles-universal molecular toolboxes

21 January 2018

1 reference

Virus-like particles as particulate vaccines

21 January 2018

1 reference

A universal influenza A vaccine based on the extracellular domain of the M2 protein

21 January 2018

1 reference

Effective subunit vaccines against an enveloped animal virus

21 January 2018

1 reference

Formation of virosomes from influenza subunits and liposomes

21 January 2018

1 reference

Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation

21 January 2018

1 reference

Preparation of recombinant HIV-1 gag protein and assembly of virus-like particles in vitro.

21 January 2018

1 reference

Epaxal: a virosomal vaccine to prevent hepatitis A infection

21 January 2018

1 reference

Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine

21 January 2018

1 reference

A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study

21 January 2018

1 reference

A randomized placebo-controlled phase Ia malaria vaccine trial of two virosome-formulated synthetic peptides in healthy adult volunteers

21 January 2018

1 reference

Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial

21 January 2018

1 reference

Virosomes for antigen and DNA delivery

21 January 2018

1 reference

Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations

21 January 2018

1 reference

Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs

21 January 2018

1 reference

Modified influenza virosomes: recent advances and potential in gene delivery.

21 January 2018

1 reference

Lipid composition of virosomes modulates their fusion efficiency with cryopreserved bull sperm cells

21 January 2018

1 reference

Preservation of influenza virosome structure and function during freeze-drying and storage

21 January 2018

1 reference

Peptides delivered by immunostimulating reconstituted influenza virosomes

21 January 2018

1 reference

Preclinical profiling of the immunogenicity of a two-component subunit malaria vaccine candidate based on virosome technology

21 January 2018

1 reference

Respiratory syncytial virus subunit vaccine based on a recombinant fusion protein expressed transiently in mammalian cells

21 January 2018

1 reference

Virosome-based active immunization targets soluble amyloid species rather than plaques in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccine.

21 January 2018

1 reference

Identification of a synthetic peptide inducing cross-reactive antibodies binding to Rhipicephalus (Boophilus) decoloratus, Rhipicephalus (Boophilus) microplus, Hyalomma anatolicum anatolicum and Rhipicephalus appendiculatus BM86 homologues

21 January 2018

1 reference

The virosome concept for influenza vaccines

21 January 2018

1 reference

Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity.

21 January 2018

1 reference

Virus-like particles as immunogens

21 January 2018

1 reference

Nanoparticles target distinct dendritic cell populations according to their size

21 January 2018

1 reference

Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells

21 January 2018

1 reference

Dendritic cell activation by recombinant hemagglutinin proteins of H1N1 and H5N1 influenza A viruses

21 January 2018

1 reference

In vitro stimulation of human influenza-specific CD8+ T cells by dendritic cells pulsed with an influenza virus-like particle (VLP) vaccine

21 January 2018

1 reference

Viral recognition by Toll-like receptors

21 January 2018

1 reference

Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation

21 January 2018

1 reference

Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors

21 January 2018

1 reference

Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies

21 January 2018

1 reference

High prevalence of influenza specific antibody secreting cells in nasal mucosa

21 January 2018

1 reference

Contribution of influenza immunity and virosomal-formulated synthetic peptide to cellular immune responses in a phase I subunit malaria vaccine trial

21 January 2018

1 reference

Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial

21 January 2018

1 reference

Influenza vaccines: the virosome concept

21 January 2018

1 reference

The virosomal adjuvanted influenza vaccine

21 January 2018

1 reference

Inflexal V--the influenza vaccine with the lowest ovalbumin content

21 January 2018

1 reference

Intranasal immunization against influenza

21 January 2018

1 reference

Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly

21 January 2018

1 reference

Optimized Malaria-antigens delivered by immunostimulating reconstituted influenza virosomes

21 January 2018

1 reference

Influenza virosomes: a flu jab for malaria?

21 January 2018

1 reference

A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial

21 January 2018

1 reference

HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis

21 January 2018

1 reference

Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis

21 January 2018

1 reference

Perspectives: towards a peptide-based vaccine against hepatitis C virus.

21 January 2018

1 reference

Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis

21 January 2018

1 reference

Freeing vaccine adjuvants from dangerous immunological dogma

21 January 2018

1 reference

Efficient delivery of DNA to dendritic cells mediated by influenza virosomes

21 January 2018

1 reference

Virosomes can enter cells by non-phagocytic mechanisms

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.11.15

1 reference

24 August 2017

1 reference